Koers Achieve Life Sciences Inc Nasdaq
Aandelen
US68230A1060
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 170 mln. 156 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -34 mln. -31,2 mln. | Nettowinst (verlies) 2025 * | -39 mln. -35,79 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,49
x | K/w-verhouding 2025 * |
-5,26
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,31% |
Recentste transcriptie over Achieve Life Sciences Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 01-08-14 |
Richard Stewart
CHM | Chairman | 65 | 01-05-15 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 14-03-22 |
Thomas King
BRD | Director/Board Member | 69 | 29-03-23 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 46,56 mld. | |
+45,38% | 41,67 mld. | |
+0,69% | 41,16 mld. | |
+30,52% | 32,4 mld. | |
+22,30% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+49,25% | 14,52 mld. | |
+49,18% | 13,74 mld. | |
+3,45% | 12,17 mld. |